Magazine Article | June 1, 2023

New DSCSA Compliance Blueprint Includes FDA & Industry Input

Source: Life Science Leader

By Eric Marshall and Zach Howard

As we approach the final phase of a 10-year rollout of the Drug Supply Chain Security Act (DSCSA), which aims to create a more secure, interoperable drug supply chain in the U.S., pharma manufacturers, distributors, and pharmacies must all ensure they are ready for its full implementation starting on Nov. 27, 2023. Specifically, the DSCSA requires all trading partners in the pharma supply chain — that is, manufacturers, wholesalers, and dispensers — to implement secure, interoperable electronic systems and processes to uniquely serialize each individual drug package in the supply chain and trace its distribution.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader